Karyopharm Therapeutics reported $23.48M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Amgen AMGN:US $ 5327M 250M
AstraZeneca AZN:LN 789.49B 100.39B
Astrazeneca AZN:US 9.61B 562M
Avrobio Inc AVRO:US 2.96M 116K
Biocryst Pharmaceuticals BCRX:US $ 41.49M 5.08M
Bristol Myers Squibb BMY:US $ 12540M 4029M
Eli Lilly And LLY:US $ 7672.4M 133.3M
Enanta Pharmaceuticals ENTA:US $ 48.21M 0.74M
Epizyme EPZM:US $ 11.21M 5.31M
GlaxoSmithKline GSK:LN 687B 192.7B
Karyopharm Therapeutics KPTI:US $ 23.48M 1.51M
Macrogenics MGNX:US $ 18.38M 3.48M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Nektar Therapeutics NKTR:US $ 10.01M 20.21M
Novartis NOVN:VX 8.91B 232M
Novartis NVS:US $ 8910M 232M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sangamo Biosciences SGMO:US $ 6.29M 1M
Takeda 4502:JP Y 794092M 69715M
Ultragenyx Pharmaceutical RARE:US $ 37.21M 8.84M
Xencor XNCR:US $ 54.28M 38.92M
YTE INCY:US $ 682.97M 120.62M